FDA Inspection 1069084 — Csaba Ivok
The FDA completed an inspection of Csaba Ivok on Sep 14, 2018 in Baja. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 14, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Baja (Hungary)
Additional Details
Clinical Investigator (CI)